Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha
- PMID: 1318324
- PMCID: PMC295883
- DOI: 10.1172/JCI115789
Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha
Abstract
Infection by herpesviruses can result in profound immunosuppressive or immunomodulatory effects. However, no significant information is available on the effect of such infections on the production of immunoregulatory cytokines. We studied the kinetics of production of two monocyte-derived cytokines, interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF alpha), induced by Epstein-Barr virus (EBV) and herpes simplex virus type 1 (HSV-1) in peripheral blood mononuclear cell cultures and in fractionated cell populations. We observed that, when compared to HSV-1, EBV is a stronger inducer of IL-6. In EBV-infected cultures, IL-6 protein was detected at day 1 postinfection and gradually increased with time. In contrast, lower amounts of IL-6 were detected 5 d postinfection in HSV-1-infected cultures. HSV-1-infected cultures secreted significant amounts of TNF alpha protein after 5 d of culture and reached a maximal level of production at day 7, whereas EBV inhibited TNF alpha production. In fractionated cell populations, monocytic cells were found to be the main source of IL-6 synthesis after EBV or HSV-1 infection. However, TNF alpha synthesis in HSV-1-infected cultures was from both B and monocytic cells. By using the polymerase chain reaction technique we show that, after infection by these two herpesviruses, differences in cytokine gene products are also observed at the transcriptional level. These observations demonstrate that EBV and HSV-1 exert differential effects on IL-6 and TNF alpha gene transcription and on the resulting protein secretion in human mononuclear blood cells.
Similar articles
-
Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study.J Immunol. 1992 Jul 1;149(1):181-7. J Immunol. 1992. PMID: 1318897
-
Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2302-12. Invest Ophthalmol Vis Sci. 1996. PMID: 8843914
-
Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus.Eur J Immunol. 1991 Jan;21(1):203-8. doi: 10.1002/eji.1830210130. Eur J Immunol. 1991. PMID: 1846816
-
Clinical and immunological considerations in Epstein-Barr virus-associated diseases.Scand J Infect Dis Suppl. 1996;100:72-82. Scand J Infect Dis Suppl. 1996. PMID: 8860357 Review.
-
[Molecular mechanism of alpha-herpesvirus proliferation].Nihon Rinsho. 2000 Apr;58(4):773-8. Nihon Rinsho. 2000. PMID: 10774194 Review. Japanese.
Cited by
-
Cytokine Storm Syndromes Associated with Epstein-Barr Virus.Adv Exp Med Biol. 2024;1448:227-248. doi: 10.1007/978-3-031-59815-9_16. Adv Exp Med Biol. 2024. PMID: 39117818 Review.
-
Infection of primary human monocytes by Epstein-Barr virus.J Virol. 2000 Mar;74(6):2612-9. doi: 10.1128/jvi.74.6.2612-2619.2000. J Virol. 2000. PMID: 10684275 Free PMC article.
-
Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function.J Endocrinol Invest. 1994 Feb;17(2):141-55. doi: 10.1007/BF03347705. J Endocrinol Invest. 1994. PMID: 8006336 Review. No abstract available.
-
Glucocorticoids and central nervous system inflammation.J Neurovirol. 2002 Dec;8(6):513-28. doi: 10.1080/13550280290100914. J Neurovirol. 2002. PMID: 12476346 Review.
-
Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo.Clin Diagn Lab Immunol. 1995 Mar;2(2):209-13. doi: 10.1128/cdli.2.2.209-213.1995. Clin Diagn Lab Immunol. 1995. PMID: 7697531 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources